Topical ketorolac 0.5% for ocular pain relief during scatter laser photocoagulation with 532 nm green laser

Basit Öğe Kaydı
dc.authoridEsgin, Haluk/0000-0002-6611-6132
dc.authorwosidEsgin, Haluk/H-6460-2013
dc.contributor.authorEsgin, Haluk
dc.contributor.authorSamut, Hasan Semih
dc.date.accessioned2024-06-12T11:19:29Z
dc.date.available2024-06-12T11:19:29Z
dc.date.issued2006
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: The aim of this study was to evaluate the analgesic effect of topical ketorolac tromethamine 0.5% during scatter laser photocoagulation procedure in proliferative diabetic retinopathy patients. Methods: 60 eyes of 30 consecutive proliferative diabetic retinopathy patients were included to this prospective, randomized, double-masked, controlled study. One (1) h before laser treatment session, ketorolac tromethamine 0.5% was instilled to 1 eye and artificial tear drop to the fellow eye. Just after treatment, the patients were asked for the severity of pain in both eyes. Visual analog scale was used to assess the level of pain. Results: Mean pain level for placebo-instilled eyes was 4.88 +/- 2.56 and ketorolac instilled eyes were 4.45 +/- 2.25. There was no significant difference for pain levels between placebo and ketorolac-instilled eyes (P = 0.29). Conclusions: Topical ketorolac tromethamine usage is no more effective than artificial tears for pain relief during posterior segment laser procedures in proliferative diabetic retinopathy patients.en_US
dc.identifier.doi10.1089/jop.2006.22.460
dc.identifier.endpage464en_US
dc.identifier.issn1080-7683
dc.identifier.issn1557-7732
dc.identifier.issue6en_US
dc.identifier.pmid17238814en_US
dc.identifier.scopus2-s2.0-33846251355en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage460en_US
dc.identifier.urihttps://doi.org/10.1089/jop.2006.22.460
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25219
dc.identifier.volume22en_US
dc.identifier.wosWOS:000243450900010en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofJournal Of Ocular Pharmacology And Therapeuticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNonsteroidal Antiinflammatory Drugsen_US
dc.subjectRadial Keratotomyen_US
dc.subjectPhotorefractive Keratectomyen_US
dc.subjectOphthalmic Solutionen_US
dc.subjectAnalgesic Efficacyen_US
dc.subjectDiclofenacen_US
dc.subjectTromethamineen_US
dc.subjectSurgeryen_US
dc.subjectSafetyen_US
dc.subjectSodiumen_US
dc.titleTopical ketorolac 0.5% for ocular pain relief during scatter laser photocoagulation with 532 nm green laseren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu